ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? (Q39836663)

15 September 2017

title

ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? (English)

1 reference

15 September 2017

1 reference

W B Melenhorst

1

1 reference

15 September 2017

L Visser

2

1 reference

15 September 2017

A Timmer

3

1 reference

15 September 2017

M C van den Heuvel

4

1 reference

15 September 2017

C A Stegeman

5

1 reference

15 September 2017

H van Goor

6

1 reference

15 September 2017

publication date

17 June 2009

1 reference

American Journal of Physiology - Renal Physiology

15 September 2017

published in

1 reference

15 September 2017

volume

297

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

F781-90

1 reference

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Remarkable roles of proteolysis on and beyond the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

ADAMs: key components in EGFR signalling and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Mitogenic effects of EGF/TGF alpha and immunolocalization of cognate receptors in human fetal kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

ErbB receptors: directing key signaling networks throughout life

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Upregulation of ADAM19 in chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90610.2008

10.1152/AJPRENAL.90610.2008

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference